We are finally getting what we asked for: Pharma is ponying up for head to head studies to provide us with meaningful data to help make better clinical decisions. However, these valuable projects are often with systemic agents, such as biologics, leaving topical treatments in the dust.
To address this, Dr. Lawrence Eichenfield, Professor of Dermatology and Pediatrics, UCSD, and colleagues sought to make the most out of the data we do have on the litany of topical options for atopic dermatitis and provide efficacy and safety guidance (A for effort!).
Tune in to hear what this dream team concocted about creams. Hear how an expert approaches new atopic dermatitis patients. Don’t miss out – this is all very topical.
Listen Now
You May Also Like
JDD Podcast: Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin
JDD Podcast: Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin
Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin Guest: Dr. Peter Lio The JDD Podcast returns with Part 2 of "Behind the Bottle", hosted…
From Crushing Childhood Challenges to Champion of Corticosteroid Stewardship: An Eczema Patient’s Perspective
From Crushing Childhood Challenges to Champion of Corticosteroid Stewardship: An Eczema Patient’s Perspective
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast's Steroid Stewardship Series,…
Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri
Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri
In Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri, guest host Dr. Vishal A. Patel, Associate Professor of Dermatology and Medicine/Oncology at the George Washington University School of Medicine…
